Our findings suggested that LWBQ capsules could reduce the expression of STAT4/STAT6 and MMP-9/TIMP-1 in patients suffering from stable COPD with lung-qi deficiency syndrome. This evidence concerns the gene STAT4 and chronic obstructive pulmonary disease.